Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed leading retina specialist, Dr. Taiji Sakamoto, an expert in the treatment ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

Waldwick, New Jersey / Syndication Cloud / January 23, 2026 / A2Z Eyecare P.C Key Takeaways Myopia and astigmatism frequently ...

The global amniotic products market is projected to grow at a CAGR of approximately 8%, reaching nearly USD 1 billion by 2031 ...

By 2050, an estimated 50% of the world's population will be nearsighted, and nearly a billion people will suffer from severe ...

Keneperu acquired new equipment to end regional surgery delays. New Zealand has expanded public hospital eye surgery services ...

Centre for Sight enhances eye care across the region, offering advanced services and a multi-centre network to ensure comprehensive patient support.

Vietnamese experts warn that myopia is spreading rapidly in schools, with some institutions reporting rates as high as 90%.

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive alternative to glasses or surgery. Phase 3 trials demonstrated superior ...

The worsening of nearsightedness in children has become a global problem. A new Israeli study points to a simple solution that may reduce the future risk of severe eye problems.

In this Healio Video Perspective from Retina 2026, Ehsan Rahimy, MD, discusses the potential of IL-6 inhibition for the ...

An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...